These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2392126)

  • 21. Circadian rhythm of covalent modifications in liver DNA.
    Nath RG; Vulimiri SV; Randerath K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):545-50. PubMed ID: 1449504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 32P-postlabelled DNA adducts in liver obtained from women treated with tamoxifen.
    Martin EA; Rich KJ; White IN; Woods KL; Powles TJ; Smith LL
    Carcinogenesis; 1995 Jul; 16(7):1651-4. PubMed ID: 7614701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine by immunoaffinity/32P-postlabelling in liver and lung DNA of mice treated with ethyl carbamate (urethane) or its metabolites.
    Fernando RC; Nair J; Barbin A; Miller JA; Bartsch H
    Carcinogenesis; 1996 Aug; 17(8):1711-8. PubMed ID: 8761431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered fidelity of a nucleic acid modifying enzyme, T4 polynucleotide kinase, by safrole-induced DNA damage.
    Randerath K; Gupta KP; van Golen KL
    Carcinogenesis; 1993 Aug; 14(8):1523-9. PubMed ID: 8102596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole.
    Miller JA; Miller EC
    Br J Cancer; 1983 Jul; 48(1):1-15. PubMed ID: 6191767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.
    White IN; de Matteis F; Davies A; Smith LL; Crofton-Sleigh C; Venitt S; Hewer A; Phillips DH
    Carcinogenesis; 1992 Dec; 13(12):2197-203. PubMed ID: 1473224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo genotoxicity and DNA adduct levels in the liver of rats treated with safrole.
    Daimon H; Sawada S; Asakura S; Sagami F
    Carcinogenesis; 1998 Jan; 19(1):141-6. PubMed ID: 9472705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity and genotoxicity of methyleugenol and related congeners-- a mechanism of activation for methyleugenol.
    Burkey JL; Sauer JM; McQueen CA; Sipes IG
    Mutat Res; 2000 Sep; 453(1):25-33. PubMed ID: 11006409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and characterization of DNA adducts produced by alkenylbenzenes in fetal turkey and chicken livers.
    Kobets T; Cartus AT; Fuhlbrueck JA; Brengel A; Stegmüller S; Duan JD; Brunnemann KD; Williams GM
    Food Chem Toxicol; 2019 Jul; 129():424-433. PubMed ID: 31077736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 32P-postlabelling of DNA adducts in styrene oxide-modified DNA and in workers exposed to styrene.
    Vodicka P; Hemminki K
    IARC Sci Publ; 1993; (127):109-18. PubMed ID: 8070856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of the 32P-postlabelling assay to the inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA adduct formation by dietary fatty acids.
    Schut HA; Zu HX
    IARC Sci Publ; 1993; (124):181-8. PubMed ID: 8225482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo.
    Phillips DH; Miller JA; Miller EC; Adams B
    Cancer Res; 1981 Jul; 41(7):2664-71. PubMed ID: 7248936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
    Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
    Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dosimetry of DNA adducts in C3H mice treated with glycidaldehyde.
    Steiner S; Crane AE; Watson WP
    Carcinogenesis; 1992 Jan; 13(1):119-24. PubMed ID: 1733564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vivo formation and repair of DNA adducts from 1'-hydroxysafrole.
    Phillips DH; Hanawalt PC; Miller JA; Miller EC
    J Supramol Struct Cell Biochem; 1981; 16(1):83-90. PubMed ID: 7299840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of malonaldehyde-modified 2'-deoxyguanosine-3'-monophosphate and DNA by 32P-postlabelling.
    Vaca CE; Vodicka P; Hemminki K
    Carcinogenesis; 1992 Apr; 13(4):593-9. PubMed ID: 1576712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo formation of N7-guanine DNA adduct by safrole 2',3'-oxide in mice.
    Shen LC; Chiang SY; Lin MH; Chung WS; Wu KY
    Toxicol Lett; 2012 Sep; 213(3):309-15. PubMed ID: 22820429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recoveries of DNA adducts of polycyclic aromatic hydrocarbons in the 32P-postlabelling assay.
    Segerbäck D; Vodicka P
    Carcinogenesis; 1993 Dec; 14(12):2463-9. PubMed ID: 8269613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.